About 8% of U.S. children have a food allergy, and that number is on the rise. Avoiding the allergic trigger is recommended, but it’s not always possible.

Desensitization therapy, while not a cure, may alleviate some fear of accidental exposure by training the immune system to adapt.

In September 2019, an FDA expert panel recommended approval of a first-of-its-kind treatment — an oral immunotherapy medication to gradually build tolerance to peanut exposure.

In this video, learn more about why this therapy for peanut allergies is one of Cleveland Clinic’s Top 10 Medical Innovations for 2020.